Literature DB >> 1424304

Detection and clinical usefulness of urinary interleukin-6 in the diseases of the kidney and the urinary tract.

K Ohta1, N Takano, A Seno, A Yachie, T Miyawaki, H Yokoyama, N Tomosugi, E Kato, N Taniguchi.   

Abstract

Interleukin-6 (IL-6) plays a key role in inflammatory and immune responses in the host. In the present study, the IL-6 activity in urine from patients with various renal diseases was examined to elucidate the pathological and clinical significance of urinary IL-6. In patients with mesangial proliferative glomerulonephritis (mes-PGN) including, IgA nephropathy, the urinary IL-6 activity tended to increase with the progression of mesangial hypercellularity. In four patients with IgA nephropathy, urinary IL-6 activity increased markedly but transiently during episodes of acute exacerbation associated with upper respiratory tract infection. In addition, it was demonstrated that urine from patients with other types of PGN such as poststreptococcal acute glomerulonephritis and membrano-proliferative glomerulonephritis contained large quantities of IL-6. However, the levels of urinary IL-6 activity were almost within the normal range in non-proliferative glomerular diseases such as membranous nephropathy, minimal change nephrotic syndrome and lupus nephritis (WHO class I and V), non-glomerular bleeding and orthostatic proteinuria. It should be noted that a marked increase in urinary IL-6 was often observed in the patients with urinary tract infection. These results indicated that IL-6 in urine might be derived from various types of cells participating in inflammatory reactions not only in the renal parenchyma but also in the urinary tract.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1424304

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  7 in total

1.  Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.

Authors:  D Karpman; A Andreasson; H Thysell; B S Kaplan; C Svanborg
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

2.  Profiles of immunoregulatory cytokine production in vitro in patients with IgA nephropathy and their kindred.

Authors:  V Scivittaro; L Gesualdo; E Ranieri; C Marfella; S A Schewn; S N Emancipator; F P Schena
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

3.  Increased levels of urinary interleukin-6 in Kawasaki disease.

Authors:  K Ohta; A Seno; N Shintani; E Kato; A Yachie; H Seki; T Miyawaki; N Taniguchi
Journal:  Eur J Pediatr       Date:  1993-08       Impact factor: 3.183

4.  Interleukin-6 and interleukin-8 in the urine of children with acute pyelonephritis.

Authors:  K Tullus; O Fituri; L G Burman; B Wretlind; A Brauner
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

5.  Streptococcal exotoxin B increases interleukin-6, tumor necrosis factor alpha, interleukin-8 and transforming growth factor beta-1 in leukocytes.

Authors:  Ninoska Viera; Adriana Pedreanez; Jaimar Rincon; Jesus Mosquera
Journal:  Pediatr Nephrol       Date:  2007-05-25       Impact factor: 3.714

6.  Urine interleukin-6 and interleukin-8 in children with acute pyelonephritis, in relation to DMSA scintigraphy in the acute phase and at 1-year follow-up.

Authors:  K Tullus; O Fituri; T Linné; R Escobar-Billing; I Wikstad; A Karlsson; L G Burman; B Wretlind; A Brauner
Journal:  Pediatr Radiol       Date:  1994

7.  Evaluation of Tubular Dysfunction Using Urine Biomarkers in Children with COVID-19.

Authors:  Nesrin Taş; Arife Uslu Gökçeoğlu; Kübra Aykaç; Burcu Ceylan Cura Yayla; Mehmet Şeneş; Leyla Demirkapı; Emel Çolak Samsun
Journal:  Turk Arch Pediatr       Date:  2022-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.